Literature DB >> 6702507

Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.

G de Gaetano, V Bertelé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6702507     DOI： 10.1007/bf01966842

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


× No keyword cloud information.
  25 in total

Review 1.  Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Authors:  S Moncada; J R Vane
Journal:  Pharmacol Rev       Date:  1978-09       Impact factor: 25.468

2.  Aspirin and thromboembolism--a possible dilemma.

Authors:  A J Marcus
Journal:  N Engl J Med       Date:  1977-12-08       Impact factor: 91.245

3.  Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator.

Authors:  W Weimar; J Stibbe; A J van Seyen; A Billiau; P De Somer; D Collen
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

4.  Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase.

Authors:  H M Tyler; C A Saxton; M J Parry
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

5.  Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour.

Authors:  S Heptinstall; J Bevan; S R Cockbill; S P Hanley; M J Parry
Journal:  Thromb Res       Date:  1980-10-15       Impact factor: 3.944

6.  Ticlopidine - an antiplatelet drug: effects in human volunteers.

Authors:  J R O'Brien; M D Etherington; R D Shuttleworth
Journal:  Thromb Res       Date:  1978-08       Impact factor: 3.944

7.  Effect of ticlopidine on arachidonic acid metabolism in platelet phospholipids in vitro.

Authors:  H Chap; M F Simon; L Douste-Blazy
Journal:  Biochem Pharmacol       Date:  1981-06-15       Impact factor: 5.858

8.  Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis--a multicenter collaborative double blind study.

Authors:  K Kobayashi; K Maeda; S Koshikawa; Y Kawaguchi; N Shimizu; C Naito
Journal:  Thromb Res       Date:  1980-10-15       Impact factor: 3.944

9.  Effects of long term administration of ticlopidine on platelet function and hemostatic variables.

Authors:  J Conard; C Lecrubier; P Y Scarabin; M H Horellou; M Samama; M G Bousser
Journal:  Thromb Res       Date:  1980-10-01       Impact factor: 3.944

10.  Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins.

Authors:  D R Phillips; P P Agin
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808
View more
  3 in total

Review 1.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

Review 2.  Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.

Authors:  E Saltiel; A Ward
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

3.  Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.

Authors:  G Di Minno; A M Cerbone; P L Mattioli; S Turco; C Iovine; M Mancini
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.